PHARMACEUTICAL EXECUTIVE NEWSLETTER

In this ISSUE

Trump Blasts FDA “Restraints,” High Drug Prices

Years of Austerity Ahead for European Healthcare

Leveraging Cognitive Search and Search-Based Applications

Rare Diseases

Pushback on Rare Drug Prices: Not So Rare After All

As medical communities across the world commemorated Rare Disease Day, it’s a good moment to sound a warning that providers of rare medicines may be the next to land in the hot seat.
... /Read more/

Executive Profile

The UK's Catapult to Drug Discovery Collaboration

Pharm Exec speaks to Chris Molloy, CEO of the newly established Medicines Discovery Catapult, which aims to establish new approaches to grow and sustain the UK's reputation for innovative, fast-to-patient drug discovery.
... /Read more/

Industry Trends

The Changing Face of Pharma and Biotech Interim Management

Geoff Newman looks at how pharma and biotech interim management has evolved in the last 20 years.
... /Read more/

Regulatory Affairs

Playing NICE with the Pharma Industry

Leela Barham looks at NICE's new position statement, which seeks to set out more clearly how it works with industry.
... /Read more/

Executive Profile

A Vision for Vaccines

Pharm Exec talks to Hugo Fry, Sanofi’s General Manager for the UK and General Manager for Sanofi Pasteur UK and Ireland, about his vision for the company and the vaccine space in these markets.
... /Read more/

Calendar

/ DCAT Week ’17 3/20-3/23 /

/ West Coast Medical Education & Research Grants Breakthrough Summit 4/4-4/5 /

/ 7th Annual Global Transparency Reporting Congress 4/4-4/5 /

Biologics Manufacturing – Is Your Company Ready?
On Demand

Learn more

update my profile / advertise with us / print & digital subscribe / visit pharmexec.com